Cancidas Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
Conditions:   Leukemia,;   Allogeneic Hematopoietic Stem Cell TransplantationIntervention:   Drug: Caspofugin + voriconazole or amphotericin BSponsor:   Shanghai Jiao Tong University School of MedicineRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2011 Category: Research Source Type: clinical trials